Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Baseimmune logo — Pioneering the next generation of active immunotherapies for...

Baseimmune

Pioneering the next generation of active immunotherapies for chronic diseases

Founded 2019 United Kingdom London, United Kingdom 29 employees Series A Total: $13.19M Biotechnology, Health Care +1

General Information

Company Name Baseimmune
Founded Year 2019
Location United Kingdom London, United Kingdom
Employees 29
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Business Model B2B, Platform
Revenue Model Licensing, Project Based
Offices as of Sep 2026
London, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Baseimmune. To contact Baseimmune, visit baseimmune.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Baseimmune compare?

A PDF of Baseimmune and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Baseimmune soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Baseimmune

Baseimmune is a UK-based company founded in 2019, marking its presence in the Biotechnology, Health Care, and Life Sciences industries. Emphasizing its slogan, "Pioneering the next generation of active immunotherapies for chronic diseases," the company operates in the specialized area of antigen discovery and vaccine development.

The recent successful closure of a £9.00M Series A investment on 01 February 2024 illustrates growing confidence in Baseimmune's innovative capabilities. Esteemed investors such as Hoxton Ventures, Beast Ventures, Creator Fund, IQ Capital, Maki.vc, and the MSD Global Health Innovation Fund participated in this funding round, highlighting significant support for the company's growth trajectory.

Future prospects for Baseimmune are bolstered by its strategic positioning in addressing chronic diseases via cutting-edge immunotherapies, a promising avenue within its field of operation. The firm remains a compelling consideration for investors interested in innovative healthcare solutions with long-term potential.

Business keywords: Active Immunotherapies, Chronic Diseases, Antigen Discovery, Vaccine Development, Biotech Startup, Next Generation Vaccines, Discovery Phase, Immunology, Biotechnology Innovation, Healthtech Startup, Biomedical Research, Preventive Medicine, Pharmaceutical Research

Services & Products

design and development of novel immunotherapies
platform for bespoke antigen creation

Target Customers

patients with chronic diseases healthcare providers and professionals biotech and pharmaceutical companies

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A £9.00M 6
Hoxton Ventures Beast Ventures Creator Fund
Hoxton Ventures, Beast Ventures +4
01 Feb 2024
Seed £3.50M 6
Cherry Ventures Hoxton Ventures Beast Ventures
Cherry Ventures, Hoxton Ventures +4
01 Nov 2021
Seed £690.00K 3
Creator Fund Maki.vc
Creator Fund, Maki.vc +1
01 Apr 2021
Support Program Undisclosed 1
KQ Labs
KQ Labs
01 Dec 2019

Latest News

View All
Bristol-based Empirical Ventures targets €11.6 million fund to lead early-stage deep science rounds — Eu-startups
Bristol-based Empirical Ventures targets €11.6 million fund to lead early-stage deep science rounds
Eu-startups Apr 04, 2024

Baseimmune Alternatives & Competitors

View All Alternatives
Baseimmune vs
LYNK Pharmaceuticals
LYNK Pharmaceuticals

Pioneering novel treatments for oncology, immunology, and inflammatory diseases since 2018.

Series C
11-50 employees
Biotechnology, Health Care
Compare Baseimmune vs LYNK Pharmaceuticals
Baseimmune vs
SpyBiotech
SpyBiotech United Kingdom

Utilizing unique protein superglue technology to develop vaccines against infectious disease and can...

Grant
23 employees
Biotechnology, Life Sciences
Baseimmune vs
Tangram Therapeutics
Tangram Therapeutics United Kingdom

Relentless medicine discovery.

Venture round
32 employees
Biotechnology, Health Care
View all alternatives

FAQ About Baseimmune

Pioneering the next generation of active immunotherapies for chronic diseases
Baseimmune was founded in 2019.
Baseimmune is headquartered in London, United Kingdom.
Baseimmune operates in Biotechnology, Health Care and Life Sciences. Its work centres on Active Immunotherapies, Chronic Diseases, Antigen Discovery and Vaccine Development. Its customers include patients with chronic diseases, healthcare providers and professionals and biotech and pharmaceutical companies.
Baseimmune has a B2B and Platform business model. Its revenue comes from Licensing and Project Based.
Baseimmune has approximately 29 employees.
Baseimmune has completed 4 funding rounds, raising a total of $13.19M. The latest funding stage is Series A.
Baseimmune offers: design and development of novel immunotherapies, platform for bespoke antigen creation.
Top alternatives and competitors to Baseimmune include LYNK Pharmaceuticals, SpyBiotech, Tangram Therapeutics, Affinivax Inc., ILiAD Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Baseimmune and LYNK Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Baseimmune, https://bouncewatch.com/company/baseimmune, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes